| Date | Time | Source | Headline | Symbol | Company |
| 05/02/2024 | 2:07PM | iHub Newswire | FeaturedNanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon | | |
| 05/02/2024 | 8:00AM | GlobeNewswire Inc. | Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended March 31, 2024 and Declaration of Distributions on Common Stock for the Months Ending July 31, August 31, and September 30, 2024 | NASDAQ:OXSQ | Oxford Square Capital Corporation |
| 04/26/2024 | 3:16PM | GlobeNewswire Inc. | Oxford Square Capital Corp. Schedules First Quarter 2024 Earnings Release and Conference Call for May 2, 2024 | NASDAQ:OXSQ | Oxford Square Capital Corporation |
| 03/15/2024 | 8:00AM | GlobeNewswire Inc. | Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended December 31, 2023 and Declaration of Distributions on Common Stock for the Months Ending April 30, May 31, and June 30, 2024. | NASDAQ:OXSQ | Oxford Square Capital Corporation |
| 03/12/2024 | 10:37AM | GlobeNewswire Inc. | Oxford Square Capital Corp. Schedules Fourth Quarter 2023 Earnings Release and Conference Call for March 15, 2024 | NASDAQ:OXSQ | Oxford Square Capital Corporation |
| 12/21/2023 | 4:44PM | Edgar (US Regulatory) | Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities | NASDAQ:OXSQ | Oxford Square Capital Corporation |
| 11/21/2023 | 8:31AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:OXSQ | Oxford Square Capital Corporation |
| 11/21/2023 | 8:30AM | Edgar (US Regulatory) | Form N-23C-2 - Notice by closed-end investment companies of intent to purchase their own securities | NASDAQ:OXSQ | Oxford Square Capital Corporation |
| 11/08/2023 | 4:57PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:OXSQ | Oxford Square Capital Corporation |
| 11/08/2023 | 4:55PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:OXSQ | Oxford Square Capital Corporation |
| 11/07/2023 | 8:00AM | GlobeNewswire Inc. | Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended September 30, 2023 and Declaration of Distributions on Common Stock for the Months Ending January 31, February 29, and March 31, 2024 | NASDAQ:OXSQ | Oxford Square Capital Corporation |
| 11/02/2023 | 4:32PM | GlobeNewswire Inc. | Oxford Square Capital Corp. Schedules Third Quarter 2023 Earnings Release and Conference Call for November 7, 2023 | NASDAQ:OXSQ | Oxford Square Capital Corporation |
| 10/04/2023 | 8:31AM | Edgar (US Regulatory) | Form N-23C-2 - Notice by closed-end investment companies of intent to purchase their own securities | NASDAQ:OXSQ | Oxford Square Capital Corporation |
| 10/04/2023 | 8:31AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:OXSQ | Oxford Square Capital Corporation |
| 08/28/2023 | 4:05PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:OXSQ | Oxford Square Capital Corporation |
| 08/23/2023 | 8:25AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:OXSQ | Oxford Square Capital Corporation |
| 08/22/2023 | 4:48PM | Edgar (US Regulatory) | Form 424B2 - Prospectus [Rule 424(b)(2)] | NASDAQ:OXSQ | Oxford Square Capital Corporation |
| 08/15/2023 | 8:30AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:OXSQ | Oxford Square Capital Corporation |
| 08/11/2023 | 8:02AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:OXSQ | Oxford Square Capital Corporation |
| 08/11/2023 | 8:00AM | Edgar (US Regulatory) | Form N-23C-2 - Notice by closed-end investment companies of intent to purchase their own securities | NASDAQ:OXSQ | Oxford Square Capital Corporation |
| 08/11/2023 | 8:00AM | GlobeNewswire Inc. | Oxford Square Capital Corp. Announces Partial Redemption of 6.50% Notes Due 2024 | NASDAQ:OXSQ | Oxford Square Capital Corporation |
| 08/10/2023 | 4:09PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:OXSQ | Oxford Square Capital Corporation |
| 08/10/2023 | 8:00AM | GlobeNewswire Inc. | Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended June 30, 2023 | NASDAQ:OXSQ | Oxford Square Capital Corporation |
| 08/03/2023 | 4:37PM | GlobeNewswire Inc. | Oxford Square Capital Corp. Schedules Second Quarter 2023 Earnings Release and Conference Call for August 10, 2023 | NASDAQ:OXSQ | Oxford Square Capital Corporation |
| 07/14/2023 | 9:10AM | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material | NASDAQ:OXSQ | Oxford Square Capital Corporation |
| 07/14/2023 | 9:06AM | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements | NASDAQ:OXSQ | Oxford Square Capital Corporation |
| 07/06/2023 | 3:22PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:OXSQ | Oxford Square Capital Corporation |
| 07/06/2023 | 3:21PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:OXSQ | Oxford Square Capital Corporation |
| 07/06/2023 | 3:20PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:OXSQ | Oxford Square Capital Corporation |
| 06/22/2023 | 4:38PM | GlobeNewswire Inc. | Oxford Square Capital Corp. Announces Partial Redemption of 6.50% Notes Due 2024 | NASDAQ:OXSQ | Oxford Square Capital Corporation |